In recent years, significant progress has been achieved regarding the knowledge of the pathobiology of pulmonary hypertension (PH), which was conducted in a research effort to identify new treatment strategies. Among the 5 clinical subgroups of PH, the most common is idiopathic pulmonary arterial hypertension (PAH), associated with increased morbidity and mortality rate. Exercise capacity, WHO functional class, hemodynamic values, findings on imaging, and biomarkers of myocardial dysfunction are parameters used to predict the survival of patients with PH. This […]